| ADP | adenosine diphosphate |
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 |
| CRC | colorectal cancer |
| dMMR | deficient mismatch repair |
| EC | endometrial cancers |
| ESGO | European Society of Gynaecological Oncology |
| ESMO | European Society for Medical Oncology |
| ESTRO | European Society for Radiotherapy and Oncology |
| FIGO | Federation of Gynecology and Obstetrics |
| HGSC | High-grade serous carcinoma |
| HNPCC | Hereditary Non-Polyposis Colorectal Cancer |
| IHC | immunohistochemistry |
| LS | Lynch syndrome |
| LVSI | lymphovascular space invasion |
| MMR | mismatch repair |
| MSI | microsatellite instable |
| MSS | microsatellite stable |
| NGS | next generation sequencing |
| NSMP | non specific molecular profile |
| OC | ovarian cancer |
| PARP | poly ADP ribose polymerase |
| PCR | polymerase chain reaction |
| PD-1 | program death 1 |
| PD-L1 | program death ligand 1 |
| pMMR | proficient mismatch repair |
| POLE | polymerase ε |
| ProMisE | Proactive Molecular Risk Classifier for Endometrial Cancer |